Search results for "cancer diagnosis"

The Ansh Labs Bioactive IGF-I kit uses a highly sensitive two-site antibody method which allows detection of bioactive IGF-I. This assay enables accurate measurement and differentiation of bioactive IGF-I from total IGF-I levels. Assessment of bioactive to total IGF-I ratio will be informative and advance our understanding of IGF-I function and regulation in different physiological and disease states.

Adenosine receptor, non-muscle myosin II (NM II), MEK1, and aurora kinase inhibitor

NF-?B Pathway Inhibitor; Stabilizes I?B

AMPK activator; Mitochondrial respiratory chain complex 1 inhibitor

Leading global pharmaceutical company presented Pangaea Data’s Novel AI to automatically generate textual clinical narratives for regulatory reports

The Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for emergency use by certain labs in July 2020

Today’s activities are part of ongoing implementation of new authorities for certain over-the-counter drugs

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

High Quality Assays with Reproducible and Reliable Results

New innovation significantly reduces turnaround time while decreasing manual and error-prone steps

EPISEQ SARS-COV-2 will support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants

The company says it continues to optimize its coronavirus test amid questions about its accuracy